tiprankstipranks
Advertisement
Advertisement
Drugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
PremiumThe FlyDrugmakers delay drug launch in Europe over U.S. pricing policies, Reuters says
11d ago
Largest borrow rate increases among liquid names
Premium
The Fly
Largest borrow rate increases among liquid names
12d ago
Buy Rating on Novartis: Durable Growth from New Therapies and Late‑Stage Pipeline Offsets Near‑Term Margin Pressure and LOE Risk
Premium
Ratings
Buy Rating on Novartis: Durable Growth from New Therapies and Late‑Stage Pipeline Offsets Near‑Term Margin Pressure and LOE Risk
12d ago
Novartis price target raised to $170 from $143 at Morgan Stanley
PremiumThe FlyNovartis price target raised to $170 from $143 at Morgan Stanley
16d ago
Novartis: Late-Stage Pipeline and Pelacarsen Upside Support Buy Rating Despite Patent Headwinds
Premium
Ratings
Novartis: Late-Stage Pipeline and Pelacarsen Upside Support Buy Rating Despite Patent Headwinds
16d ago
Novartis: Strengthened Growth Outlook and Undervalued Late‑Stage Pipeline Support Buy Rating and Higher Target Price
Premium
Ratings
Novartis: Strengthened Growth Outlook and Undervalued Late‑Stage Pipeline Support Buy Rating and Higher Target Price
16d ago
Novartis: Strengthened Late-Stage Pipeline Underpins Upgraded CHF140 Target and Buy Rating
PremiumRatingsNovartis: Strengthened Late-Stage Pipeline Underpins Upgraded CHF140 Target and Buy Rating
19d ago
Novartis to acquire Pikavation Therapeutics from Synnovation Therapeutics
Premium
The Fly
Novartis to acquire Pikavation Therapeutics from Synnovation Therapeutics
22d ago
Novartis initiated with a Market Perform at Bernstein
Premium
The Fly
Novartis initiated with a Market Perform at Bernstein
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100